Maharashtra FDA Studies Karnataka's Hospital Billing Rules To Ensure Medicine Price Transparency, Considers Mandatory Disclosure Of Procurement Costs
Mumbai: The Maharashtra Food and Drug Administration (FDA) is studying Karnataka’s circular directing hospitals to disclose the procurement or landing price of medicines and medical devices on itemised bills, and is exploring whether a similar mechanism can be introduced in the state. FDA Examines Karnataka's Legal Framework “We are studying under which Act the Karnataka FDA issued the circular…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
